Form 4 for LPCN Lipocine Inc.
Accepted 2023-05-25 00:00:00 ET · period of report 2023-05-25 · accession 0001493152-23-019050 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-25 | 2023-05-25 | LPCN | Patel Mahesh V. | CEO, Pres, Dir | P - Purchase | $5.03 | +8,706 | 107.4K | +9% | +$43.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-25 | P | A | 8,706 | $5.03 | 107,418 | D | — | — | (F1) Prior to May 11, 2023, Mr. Patel held 1,678,090 shares of common stock. On May 11, 2023, the Company effected a reverse stock split at a ratio of 1-for17, which resulted in a change in Mr. Patel's shares of common stock to 98,712 as of May 11, 2023. |